← All indications
Atrophic Vaginitis
Inflammation of the vagina due to thinning of the vaginal wall and decreased lubrication associated with reduced estrogen levels at MENOPAUSE.
Drugs by status
Approved for this indication (3)
Phase 4 trials (3)
Phase 3 trials (3)
Phase 2 trials (2)
Phase 1 trials (7)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (24)
- Actavis
- Pfizer
- Mylan
- Wyeth
- Alvogen
- Mayo Clinic
- Amneal Pharmaceuticals
- Health Awareness, Inc
- Novum Pharmaceutical Research Services
- Comprehensive Clinical Trials, LLC
- Meridien Research
- Visions Clinical Research
- Horizons Clinical Research Center, LLC
- Lawrence OB/GYN Clinical Research, LLC
- Physician Care Clinical Research LLC
- Veritas Research., Corp.
- South Coast Research Center, Inc.
- OB-GYN Associates of Mid Florida
- MCB Clinical Research Centers, LLC
- Sunrise Medical Research, Inc.
- Arizona Research Associates
- AXIS Clinicals Limited
- Northern California Research Corp
- National Center for Advancing Translational Science (NCATS)
Organization Involved with Phase 2 Indications (7)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (7)